F-star Biotechnology Competitors and Similar CompaniesClear all

KemPharm's competitors and similar companies include Actinium Pharmaceuticals, Juno Therapeutics and Aceragen.

	KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.	Actinium Pharmaceuticals Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers.	Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.	Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Founding Date	Founding Date 2006	Founding Date 2000	Founding Date 2013	Founding Date 1989
Type	Type Public	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech clinics pharma platform	Tags Healthcare biotech clinics medical diagnostics pharma platform	Tags Healthcare biotech clinics pharma platform	Tags Healthcare biotech clinics pharma
Locations	Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US	Locations New York, US HQ	Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US	Locations Durham, US HQ
Employees	Employees 333% increase	Employees 2517% decrease	Employees 1091% decrease	Employees 3642% decrease
Valuation ($)	Valuation ($) 200.5 m	Valuation ($) 58.6 m	Valuation ($) N/A	Valuation ($) 3.2 m
Financial
Revenue (est.)	Revenue (est.) $106.5m (FY, 2025)	Revenue (est.) $90k (FY, 2025)	Revenue (est.) $111.9m (FY, 2017)	Revenue (est.) $4.9m (FY, 2022)
Net income	Net income $83.2m (FY, 2025)	Net income N/A	Net income ($437.1m) (FY, 2017)	Net income ($23.4m) (FY, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 7m	Total funding raised $ 310m	Total funding raised $ 13.8m